Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma

International Journal of Molecular Medicine

Volumn 18, Issue 3, 2006, Pages 395-403

  Diegmann, Julia ^a   Tomiuk, Stefan ^b   Sanjmyatav, Jimsgene ^a   Junker, Kerstin ^a   Hindermann, Winfried ^a   Von Eggeling, Ferdinand ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b MILTENYI BIOTEC GMBH   (Germany)

Author keywords

CD70; cDNA arrays; Kidney cancer; Pathway analysis; Statistical analysis of microarrays; TNFSF7

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CLUSTER ANALYSIS; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METHODOLOGY; PAPILLARY CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33750581361     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.3.395     Document Type: Article

References (28)

1. Eble JN: WHO-classification of tumors. In: Pathology and genetics of tumors of the urinary system and male genital organs. Sauter G, Epstein J and Sesterhenn I (eds). IARC Press, Lyon, 2004.
2. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B and Iczkowski K: Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 987-989, 1997.
3. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, et al: The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133, 1997.
4. Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, Molto L, Tannenbaum C, Worford LJ, Bukowski R, Tubbs R, Hsi ED, et al: Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res 5: 1219-1229, 1999. (Pubitemid 29233241)
5. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, et al: Gene-expression profiles in hereditary breast cancer. N Engl J Med 344: 539-548, 2001. (Pubitemid 32167867)
6. Boer JM, Huber WK, Sultmann H, Wilmer F, von HA, Haas S, Korn B, Gunawan B, Vente A, Fuzesi L, Vingron M and Poustka A: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 11: 1861-1870, 2001.
7. Draghici S, Khatri P, Martins RP, Ostermeier GC and Krawetz SA: Global functional profiling of gene expression. Genomics 81: 98-104, 2003. (Pubitemid 36298600)
8. Arlt D, Huber W, Liebel U, Schmidt C, Majety M, Sauermann M, Rosenfelder H, Bechtel S, Mehrle A, Bannasch D, Schupp I, Seiler M, et al: Functional profiling: from microarrays via cell-based assays to novel tumor relevant modulators of the cell cycle. Cancer Res 65: 7733-7742, 2005.
9. Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, Shih JH, Barrett JC and Birrer MJ: Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways. Oncogene 23: 8065-8077, 2004.
10. Diegmann J, Junker K, Gerstmayer B, Bosio A, Hindermann W, Rosenhahn J and von EF: Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry. Eur J Cancer 41: 1794-1801, 2005. (Pubitemid 41132643)
11. Eberwine J: Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA. Biotechniques 20: 584-591, 1996.
12. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, et al: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365-371, 2001.
13. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
14. Tusher VG, Tibshirani R and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
15. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D and Altman RB: Missing value estimation methods for DNA microarrays. Bioinformatics 17: 520-525, 2001. (Pubitemid 32600498)
16. Eisen MB, Spellman PT, Brown PO and Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998.
17. Vencio RZ, Koide T, Gomes SL and Pereira CA: Bay GO: Bayesian analysis of ontology term enrichment in microarray data. BMC Bioinformatics 7: 86, 2006.
18. Boyle EI, Weng S, Gollub J, Jin H, Botstein D, Cherry JM and Sherlock G: GO:TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20: 3710-3715, 2004. (Pubitemid 40136825)
19. Xu Q and Shaulsky G: GOAT: An R Tool for Analysing Gene Ontology trade mark Term Enrichment. Appl Bioinformatics 4: 281-283, 2005.
20. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N and Ross JS. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7: 3113-3119, 2001.
21. Gerritsen ME, Peale FV Jr and Wu T: Gene expression profiling in silico: relative expression of candidate angiogenesis associated genes in renal cell carcinomas. Exp Nephrol 10: 114-119, 2002.
22. Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de RM and Brooks JD: Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 162: 925-932, 2003.
23. Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C: KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am J Surg Pathol 28: 676-678, 2004.
24. Takahashi M, Yang XJ, Sugimura J, Backdahl J, Tretiakova M, Qian CN, Gray SG, Knapp R, Anema J, Kahnoski R, Nicol D, Vogelzang NJ, et al: Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 22: 6810-6818, 2003.
25. Shirsat NV and Shaikh SA: Overexpression of the immediate early gene fra-1 inhibits proliferation, induces apoptosis, and reduces tumourigenicity of c6 glioma cells. Exp Cell Res 291: 91-100, 2003.
26. Nakamura A, Akiyama K and Takai T: Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer. Expert Opin Ther Targets 9: 169-190, 2005. (Pubitemid 40331203)
27. Locksley RM, Killeen N and Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501, 2001.
28. Chahlavi A, Rayman P, Richmond AL, Biswas K, Zhang R, Vogelbaum M, Tannenbaum C, Barnett G and Finke JH: Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70. Cancer Res 65: 5428-5438, 2005.